Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Search in:

Advanced search

Current Medical Research and Opinion Volume 38, 2022 - Issue 6

Submit an article Journal homepage

Open access

2,667

Views

CrossRef citations to date

Altmetric

Pharmacology

A review of the totality of evidence supporting the development and approval of a pegfilgrastim biosimilar (LA-EP2006)

Sanjiv S. Agarwalaa Lewis Katz School of Medicine, Temple University, Philadelphia, PA, USA;b Cancer Expert Now, Morristown, NJ, USA

Ulrich Naglc Sandoz GmbH, Holzkirchen, Germany

Xinghua Guoc Sandoz GmbH, Holzkirchen, Germany

Anne Bellonc Sandoz GmbH, Holzkirchen, Germany

Jens Heync Sandoz GmbH, Holzkirchen, Germany

Miryana Dimova-Dobrevac Sandoz GmbH, Holzkirchen, Germany

Yu-Ming Shenc Sandoz GmbH, Holzkirchen, Germany

Gregor Schaffarc Sandoz GmbH, Holzkirchen, Germany

Martin Humphreyc Sandoz GmbH, Holzkirchen, Germany

Nicola Mathiesonc Sandoz GmbH, Holzkirchen, Germany

Natalia Koptelovac Sandoz GmbH, Holzkirchen, Germany

Sreekanth Gattuc Sandoz GmbH, Holzkirchen, GermanyCorrespondence[email protected]

show all

Pages 999-1009 | Received 22 Nov 2021, Accepted 29 Mar 2022, Published online: 17 Apr 2022

Cite this article
https://doi.org/10.1080/03007995.2022.2061707
CrossMark

Full Article
Figures & data
References
Supplemental
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF View EPUB EPUB

Supplemental material

Supp_Fig_1.eps

Download EPS Image (2 MB)

Totality_of_evidence_review_ms_Suppl_17Nov21.docx

Download MS Word (142.1 KB)

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references